Innovation: Intelligent bacteria demonstrate high efficacy in the treatment of widespread disease irritable bowel syndrome with typical symptoms of recurrent diarrhoea, abdominal pain, bloating and constipation
![Innovation: Intelligent bacteria demonstrate high efficacy in the treatment of widespread disease irritable bowel syndrome with typical symptoms of recurrent diarrhoea, abdominal pain, bloating and constipation](https://www.sttinfo.fi/data/images/00074/99d821c9-5b49-4f51-92a6-f1d4ef28c3d1.jpg)
New therapy with unique bacterial strain B. bifidum HI-MIMBb75 promises help for approximately 80 million Europeans suffering from irritable bowel syndrome1 - World's largest clinical OTC irritable bowel syndrome trial investigating the efficacy of this particular strain published in the renowned medical journal The Lancet Gastroenterology & Hepatology2 - Results show significant efficacy for all predominant irritable bowel syndrome symptoms and all subtypes while simultaneously improving patients’ quality of life2 (Gräfelfing/Munich, Germany) The world's largest OTC irritable bowel syndrome (IBS) trial comes up with remarkable results, which were recently published in the renowned medical journal The Lancet Gastroenterology & Hepatology. For the first time, leading German scientists around Prof. Dr. Peter Layer (Israelitic Hospital Hamburg) were able to prove the significant efficacy of a heat-inactivated bacterial strain on patients with IBS. Trial results show that B. bifidum HI-M
![](https://cdnintech.com/media/chapter/39618/1512345123/media/image1.png)
Probiotics Applications in Autoimmune Diseases
![](https://publinestorage.blob.core.windows.net/7a953d1a-f9f3-45ed-8b52-9852e401402e/jctg-23-26-g002.jpg)
Global Research Trends and Hot Spots in the Overlapping Fields of Functional Bowel Disorders and the Intestinal Microbiota: A Scientometric Analysis
![](https://pub.mdpi-res.com/gastrointestdisord/gastrointestdisord-04-00005/article_deploy/html/images/gastrointestdisord-04-00005-g001.png?1646312122)
Gastrointestinal Disorders, Free Full-Text
![](https://journals.sagepub.com/cms/10.1177/2050640617731968/asset/images/large/10.1177_2050640617731968-fig1.jpeg)
Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice - Paul Moayyedi, Fermín Mearin, Fernando Azpiroz, Viola Andresen, Giovanni Barbara, Maura Corsetti, Anton Emmanuel, A Pali S Hungin, Peter
![](https://www.frontiersin.org/files/Articles/609292/fpain-01-609292-HTML/image_m/fpain-01-609292-g001.jpg)
Frontiers Importance of Non-pharmacological Approaches for Treating Irritable Bowel Syndrome: Mechanisms and Clinical Relevance
![](https://www.biorxiv.org/content/biorxiv/early/2019/05/12/630350/F1.large.jpg)
A Clostridia-rich microbiota contributes to increased excretion of bile acids in diarrhea-predominant irritable bowel syndrome
![](https://www.frontiersin.org/files/Articles/808195/fphar-13-808195-HTML/image_m/fphar-13-808195-g001.jpg)
Frontiers Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders
![](https://f6publishing.blob.core.windows.net/2284f5cf-5c61-4163-a8b2-4b83dba8fd7b/WJG-28-412-g001.png)
Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome
![](https://www.degruyter.com/document/doi/10.1515/biol-2022-0741/asset/graphic/j_biol-2022-0741_fig_008.jpg)
Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis